← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2019Last known activity
Feb 19, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05194007CollaboratorPhase 2/Phase 3Feb 19, 2022
- NCT03879174Lead sponsorPhase 2Aug 1, 2019
- NCT03879174Study directorPhase 2Aug 1, 2019
Details
- Last known activity
- Feb 19, 2022